Clicky

OKYO Pharma Limited(OKYO) News

Date Title
Jul 11 OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101
Jul 10 OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
Jan 31 OKYO Pharma Announces Distinguished Ophthalmologists with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Join its Scientific Advisory Board
Jan 5 OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
Dec 4 OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit
Apr 25 OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease